Krystal Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Krystal Biotech using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $2.66 | $1.12 | 137.5 % |
| Q2 | 2025-08-04 | $1.29 | $1.29 | 0.00 % |
| Q1 | 2025-05-06 | $1.20 | $1.52 | -21.1 % |
| Q4 | 2025-02-19 | $1.52 | $1.29 | 17.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $97.80M | $92.65M | 5.56 % |
| Q2 | 2025-08-04 | $96.04M | $91.38M | 5.11 % |
| Q1 | 2025-05-06 | $88.18M | $96.21M | -8.34 % |
| Q4 | 2025-02-19 | $91.14M | $96.95M | -5.99 % |
Krystal Biotech (KRYS) is scheduled to report earnings on February 18, 2026. The last reported earnings were for reported on November 3, 2025 for Q3.
The Actual EPS was $2.66, which beat the estimate of $1.12.
The Actual Revenue was $97.8M, which beat the estimate of $92.7M.
Browse earnings estimates, EPS, and revenue on all stocks.